2/2/16
`
`
`
`
`NAME:
`
`OFFICE ADDRESS:
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`CURRICULUM VITAE
`
`
`
`Leonard Bielory, M.D.
`
`
`400 Mountain Avenue
`
`Springfield, New Jersey 07081
`
` drlbielory@gmail.com
`
`Office VOX: 973-912-9817
`Office FAX: 206-333-1884
`
`
`
`
`
`Rutgers University
`Robertwood Johnson University Hospital
`Center for Environmental Prediction
`bielory@rutgers.edu
`
`
`
`1.
`EDUCATION
`9/72 - 6/76
`B.S. -Fundamental Science, Lehigh University
`
`
`College of Engineering, Bethlehem, Pennsylvania
`9/75 - 10/76
`M.S.-Molecular Biology, Lehigh University
`
`
`Graduate School of Molecular Biology, Bethlehem, Pennsylvania
`9/76 - 5/80
`M.D.-UMDNJ-New Jersey Medical School, Newark, N.J.
`
`2. POSTDOCTORAL TRAINING
`7/80 – 6/81
`Intern, University of Maryland Hospitals
`
`
`Baltimore, Maryland
`7/81– 6/82
`Junior Assistant Resident in Medicine, University of Maryland Hospitals,
`
`
`Baltimore, Maryland
`7/82– 6/85
`Medical Staff Fellow in Hematology
`
`
`National Institutes of Health, National Heart, Lung and Blood Institute
`
`
`Bethesda, Maryland
`7/83– 6/85
`Medical Staff Fellow in Allergy and Immunology
`
`
`National Institutes of Health, National Institute of Allergy and Infectious Diseases,
`
`
`Bethesda, Maryland
`
`None
`
`
`3. MILITARY
`
`4. LICENSURE
`1985
`
`State of New Jersey Medical License (#45947) –06/07
`1981
`
`State of Maryland Medical License (#D27152) (inactive)
`1982
`
`District of Columbia Medical License (#13508) (inactive)
`1985
`
`State of Florida Medical License (ME0046373) (inactive)
`
`5. CERTIFICATION
`1984
`
`Diplomate, American Board of Internal Medicine (#091520)
`1985
`
`Diplomate, American Board of Allergy & Immunology (#003598)
`1986
`
`Diplomate, Diagnostic Laboratory Immunology (#00007)
`1980
`
`Certified in Advanced Cardiac Life Support
`1981
`
`Diplomate, National Boards (#227618)
`1982
`
`Re-certified in Advanced Cardiac Life Support
`1984
`
`Authorized User of Radioactive Materials (#8449)
`1994
`
`Certified Basic Life Support
`
`
`
`Bielory
`
`1/45
`
`000001
`
`ARGENTUM PHARM. 1025
`
`

`
`2/2/16
`
`
`6. NARCOTICS CERTIFICATION
`1985 - present New Jersey Controlled Drug Substances Reg (#D41531)
`1981 - present Drug Enforcement Agency Registration (#AB1328295)
`
`7. APPOINTMENTS
`
`
`
`
`
`1985 – 1992
`
` UMDNJ – NJ Medical School, Assistant Professor of Medicine and Pediatrics.
`1992 – 2002
`
` Associate Professor of Medicine, Pediatrics and Ophthalmology
`1985 – 2009
`
` Director, Div. of Allergy and Immunology, Department of Medicine
`1997 – 2009
`
` Director, Div. Allergy, Immunology & Rheumatology, Dept. Medicine
`1991 – 2009
` Co-Director Immuno-Ophthalmology Service, Dept of Ophthalmology
`1994 – 1995
`
` Member, University Health Care Corp. Advisory Committee
`2000 - 2008
` Member, Steering Committee, UMDNJ - National Center for the Elimination of Health
`Disparities
` Professor of Medicine, Pediatrics, Ophthalmology and Visual Sciences
` Professor, Rutgers University, Center for Environmental Prediction
` Affiliate Member, NIEHS Center for Environmental Health Sciences at the Environmental and
`Occupational Health Sciences Institute, Rutgers University and Robert Wood Johnson Medical
`School, Piscataway, New Jersey
`
`
`2002 - 2010
`2010-present
`2011-present
`
`
`8. HOSPITAL APPOINTMENTS
`1985- Present
`Saint Barnabas Medical Center, Livingston, NJ - Consultant Allergy & Immunology
`2011- Present
`Robert Wood Johnson University Hospital, New Brunswick, New Jersey
`2011 – Present Atlantic Health System, Overlook Hospital, Summit, New Jersey
`1985-2001
` Newark Beth Israel Hospital, Newark, NJ - Consultant Allergy & Immunology
`1985-2001
`United Medical Center, Newark, NJ - Consultant Allergy & Immunology
`1985 – 2010
`UMDNJ – University Hospital, Newark , New Jersey
`1985-2005
`East Orange Veterans Administration Medical Center, East Orange, NJ - Consultant Allergy &
`Immunology
`
`
`9. OTHER PROFESSIONAL POSITIONS AND MAJOR VISITING APPOINTMENTS:
`1998
`
`
`Visiting Professor, Department of Medicine, SUNY – Syracuse Medical School
`2000 William Pierson Visiting Professorship - Allergy & Immunology – SUNY Downstate
` Visiting Professor, Elliott Middleton Lectureship – SUNY Buffalo, Buffalo, N.Y.
`William Pierson Visiting Professorship for the Allergy & Immunology-Atlantic Health System
`Overlook Hospital, Summit New Jersey.
`
`2003
`
`
`10. AWARDS AND HONORS
`1975
`
`Phi Beta Kappa - Arts Honor Society
`1975
`
`Tau Beta Pi - Engineering Honor Society
`1985
`
`American College of Allergy, Asthma and Immunology - Fellows Award
`1985
`
`American College of Allergy, Asthma and Immunology - von Pirquet Award
`1985
`
`American Academy of Allergy, Asthma & Immunology - Young Investigator Award
`1985
`
`American Academy of Allergy, Asthma & Immunology - Travel Grant Award
`1985
`
`International Congress of Allergy & Clinical Immunology - Travel Grant Award
`1986
`
`Dean's Award of Clinical Excellence - UMDNJ - New Jersey Medical School
`1999
`
`American Academy of Ophthalmology Achievement Award (ID# 074606)
`2000
`
`Elliot Middleton Visiting Professorship, SUNY- Buffalo
`2001
`
`Dean’s Citation, UMDNJ-School of Health Related Professions, Newark, New Jersey
`2001
`
`Certificate of Appreciation, UMDNJ – School of Health Related Professions, Newark, New Jersey
`2001
`
`Certificate of Appreciation, UMDNJ –University Hospital Outreach Programs Newark, NJ
`
`2001-2012
`New Jersey Magazine – “Top Docs” in New Jersey
`1996-2012
`Castle, Connolly Guide - The Best Doctors-New York Metro Area
`
`
`
`
`
`
`
`
`Bielory
`
`2/45
`
`000002
`
`

`
`2/2/16
`
`1996-2012
`
`
`
`
`
`
`
`New York Magazine – “Top Docs” in New York Metropolitan Area and the New Jersey Magazine
`Best Doctors in New Jersey
`Certificate of Appreciation, UMDNJ-University Hospital Outreach Programs Newark, New Jersey
`Argentina Institute of Allergy and Immunology – XVII International Meeting – Plenary Speaker
`
`2005
`2007
`
`11. BOARD OF DIRECTORS/TRUSTEES
`1986-1995 New Jersey Medical School Alumni Association
`1991-1993
`New Jersey Allergy, Asthma and Immunology Society Executive Committee
`1992-2000
`University Physician Associates Board of Directors - New Jersey Medical School
`1994-1998
`University HealthCare Corporation Board of Trustees
`1996-1998
`President -NJMS University Physician Associates Board of Directors
`1993-1995
`Steering Committee, NJMed (New Jersey Medical School) Professional Corporation
`1996-1998
`Advisory Board, National Managed Health Care Congress
`2000-2001
`Steering Committee, UMDNJ School of Public Health
`2002-2006
`National Board Member, St. John’s Community Service, Washington, D.C.
`2003-2006
`Chairman of Board, St. John’s Community Service of New Jersey, Washington, D.C.
`2011-2014
`Member, American College of Allergy, Asthma and Immunology Board of Regents
`2012 – Present Member, Board of Health, Springfield, New Jersey
`
`12. MAJOR COMMITTEE ASSIGNMENTS
`
`a. National and Regional
`1987-2004
` Allergy and Immunology Training Program Directors
`1989-1993
`Member, American College of Physicians, Medical Knowledge Self Assessment Program
`(MKSAP) - I for Allergy & Immunology
`American Board of Allergy and Immunology Member - Recertification Examination Committee
`American Academy of Allergy and Immunology, Chairman - Immuno-Ophthalmology Committee
` Allergy and Immunology Training Program Directors, Member - Controversial Practices
`Committee
`Ex-officio member, National Institutes of Health, National Heart, Lung and Blood Data and Safety
`Monitoring Committee
`Study Chairman, National Institutes of Health, National Heart, Lung and Blood Institute,
`Raynaud's Treatment Study
`Allergy and Immunology Training Program Directors, Member - Education Committee
` Member, American College of Physicians, Medical Knowledge Self Assessment Program
`(MKSAP) -II for Allergy & Immunology
`Member, Joint Council of Asthma, Allergy and Immunology Board of Trustees
`Member, New Jersey Department of Health and Senior Services, New Jersey Minority Health
`Network on Asthma
`Chair, Dermatologic and Ocular Disease Interest Section, American Academy of Allergy, Asthma
`and Immunology
`Member, American Academy of Allergy, Asthma and Immunology Abstract Review Committee
` Member, Joint Council of Asthma, Allergy and Immunology Board of Trustees
` Vice Chair, Dermatologic Disease Interest Section, American Academy of Allergy, Asthma and
`Immunology
`Co-Chair, American Lung Association, National Committee on Technology
`Member, New Jersey Department of Health and Senior Services, New Jersey Minority Health
`Network on Asthma
`Chair, American College of Physicians, Medical Knowledge Self Assessment Program - Allergy
`& Immunology, American Academy of Allergy, Asthma and Immunology
`Member, American Academy of Allergy, Asthma and Immunology, Immuno-Ophthalmology
`Committee
`
`1991-1993
`1991-1999
`1992-1996
`
`1993-1998
`
`1993-1999
`
`1994-1996
`1994-1996
`
`1994-1996
`
`1996-1998
`1997-1999
`
`1998-1999
`1998-1999
`
`1998-2001
`
`2000-2006
`
`Bielory
`
`3/45
`
`000003
`
`

`
`2/2/16
`
`2007-2012
`
`2011-2012
`
`2011-2012
`
`2007-2012
`
`2004-2012
`
`2008-2010
`
`2004-2006
`
`200202006
`
`2002-2006
`
`2008-present
`
`Member, American Academy of Allergy, Asthma and Immunology, Immunotherapy, Rhinitis,
`Sinusitis, Ocular Dieseases & Cough Interest Section
`Plenary Representative, American Academy of Allergy, Asthma and Immunology,
`Immunotherapy, Rhinitis, Sinusitis, Ocular Dieseases & Cough Interest Section
`Plenary Subcommittee, American Academy of Allergy, Asthma and Immunology,
`Immunotherapy, Rhinitis, Sinusitis, Ocular Dieseases & Cough Interest Section Representative
`Member, American Academy of Allergy, Asthma and Immunology, Rhinitis, Rhinosinusitis,
`Ocular Allergy Committee
`2001-2006 Member, American Academy of Allergy, Asthma and Immunology, Aerobiology Committee
`2002-2003
`Chairman, Complementary & Alternative Medicine Symposium, American College of Allergy,
`Asthma and Immunology
`Member, New Jersey Department of Environmental Protection, Clean Air Council of New Jersey
`(Governor Appointed)
`Chair - New Jersey Department of Environmental Protection, Clean Air Council of New Jersey
`(Governor Appointed)
`Member, National Institutes of Health, National Center for Complementary and Alternative
`Medicine, Special Emphasis Panel, PAS 03-038, Centers of Excellence for Research on
`Complementary and Alternative Medicine
`Member, U.S. Pharmacopeia, USP Council of Experts, Medicare Model Guidelines Committee
`legislated by U.S. Congress
`Member, U.S. Pharmacopeia, USP Council of Experts, Pulmonary Disease/Allergy Expert
`Committee
`2004-2006 Chair, American Academy of Allergy, Asthma and Immunology, Complementary and Alternative
` Practices in Allergy Committee
`2004-2012 Chair, American Academy of Allergy, Asthma and Immunology, Complementary and Alternative
` Practices in Allergy Committee
`2005 -2007
`Member, American College of Allergy, Asthma and Immunology - Public Education Committee
`2005-2010
`Member, American College of Allergy, Asthma and Immunology - Abstract Review Committee
`2006-2010
`Associate Editor, Annals of Allergy, Asthma & Immunology
`2006-2008
`Member, Joint Council of Allergy and Immunology – Joint Task Force - Practice Parameters of
`Allergic Eye Disease – Diagnosis and Management
`Chair, Joint Council of Allergy and Immunology – Joint Task Force - Practice Parameters of
`Allergic Eye Disease – Diagnosis and Management
`2008-2010 Chair, ACAAI Integrative Medicine Committee
`2008-2010 Chair, ACAAI Ocular Allergy Committee
`2008-2010 Member, ACAAI Medical Informatics Committee
`2008-2010 Vice Chair, ACAAI Public Education and Outreach Committee
`2008-2010 Member, ACAAI Continuing Medical Education Committee
`2011-2015
`Member, AAAAI Complementary and Alternative Practices in Allergy Committee
`2010-2015
`Member, AAAAI, Immunotherapy, Rhinitis, Sinusitis, Ocular diseases & Cough Interest Section
`2010-2013
`Plenary Representative, AAAAI, Immunotherapy, Rhinitis, Sinusitis, Ocular diseases & Cough
`Interest Section
`IRSOC representative, AAAAI, Plenary Subcommittee
`Member, American College of Allergy, Asthma and Immunology Board of Regents
`Member, Executive Committee American College of Allergy Asthma and Immunology
`
`2010-2013
`2011-2014
`2013-2014
`
`b. Medical School
`1985-1989
`Member, UMDNJ-NJMS Institutional Review Board
`1985-1986
`Member, UMDNJ-NJMS Continuing Education Committee
`1985-1986 Member, UMDNJ-NJMS Department of Medicine, Quality Assurance Committee
`1988-1990
` Member, UMDNJ-NJMS Medical Office Complex Committee
`1988-1990
`Member, UMDNJ-NJMS Continuing Education Committee
`1988-1990
`Interviewer, UMDNJ-NJMS Admissions Committee
`1989-1993
`Member, UMDNJ-NJMS Biomedical Research Support Grant Committee
`1992-1993
`Co-Chair, UMDNJ-NJMS Biomedical Research Support Grant Committee
`1989-1995
`Member, UMDNJ-Foundation Grant Committee
`
`Bielory
`
`4/45
`
`000004
`
`

`
`2/2/16
`
`
`
`1990-1991 Member, UMDNJ-NJMS Search Committee for Chairperson, Department of Medicine
`1994-1995
`Member, UMDNJ-NJMS Managed Care Committee
`1996
`
`Member, LCME Faculty Site Visit Committee
`1996-1999
`Member, UMDNJ-NJMS Biomedical Research Support Grant Committee
`1996-1999 Member, New Jersey Medical School Continuing Medical Education Committee
`1997-1998 Member, New Jersey Medical Alumni Association Nominating Committee
`1996-1999 Member, National Institutes of Health/National Library of Medicine - Integrated Advanced
`Information Management System (IAMIS) - Technology Planning Committee
`Member, UMDNJ-NJMS Institutional Board Overview Committee
`1997-1999
`UMDNJ-NJMS-Clinical Research Subcommittee Member
`1998-2000
`UMDNJ-Neurological Institute Musical Moments Event Committee
`1997-2002
` Hospital
`
`Essex County Medical Society Hospital Relations Committee
`1993-1995
`Member-University Hospital Ambulatory Care Business Plan Committee
`1996-1997
`Co-Chairman, Medical Staff Bylaws Committee
`1997-1999
`
` Member, University Hospital Medical Record Confidentiality Committee
`
` Member, University Hospital Leadership Task Force
`
`c. Hospital
` Member, UMDNJ-University Hospital Surgical Review Committee
`1987-1988
` Member, UMDNJ-University Hospital Transfusion Committee
`1987-1990
` Member, UMDNJ-University Hospital Marketing Committee
`1987-1988
`President-Elect, UMDNJ-University Hospital Medical Staff
`1992-1993
`President, UMDNJ-University Hospital Medical Staff
`1993-1995
`Member, UMDNJ-University Hospital Joint Council
`1993-1995
`Member, UMDNJ-University Hospital CEO Search Committee
`1993-1994
`1993-1994 Member, UMDNJ- University Hospital Search Committee for Director of Ambulatory Care
`1996-1997
` Member, UMDNJ- University Hospital Search Committee for Vice President of Ambulatory
`
`
`
` CareServices
`1996-1997
` Member UMDNJ-University Hospital Space Reallocation Committee
`
`d. Department
`1990 -1996
`1996 – 2000
`2002 - 2003
`2003 - 2008
`
`e. Editorial Boards
`1988 - 1995
`Associate Editor, New Jersey Medicine
`1992 - 2004
`Editorial Board, Annals of Allergy, Asthma & Immunology
`1993 – 1997
`Editorial Board, American Journal of Asthma & Allergy for Pediatricians
`1996 – 1999
`Contributing Editor, J of Allergy and Clinical Immunology
`2004 - 2005
`Editorial Board, BMC Occupational and Environmental Medicine
`2005 – 2012
`Associate Editor, Annals of Allergy, Asthma and Immunology
`2005 - present Editorial Board, J. of Occupational Medicine and Toxicology
`1996 - present Reviewer, Journal of Allergy and Clinical Immunology
`2002 - present Reviewer, Allergy
`2002 - present Reviewer, Clinical Therapeutics
`2008 - present Reviewer, British Journal of Pharmacology
`2008 - present Reviewer, American Journal of Medicine
`
`13. MEMBERSHIPS, OFFICES AND COMMITTEE ASSIGNMENTS IN PROFESSIONAL SOCIETIES
`1993-1995
`Member, New York Academy of Sciences
`1992-1995
`Fellow, New York Academy of Medicine
`1989-1995
` Member, Association for Research in Vision & Ophthalmology Immunology Section
`(#35493)
`
`Member, NJMS-University Physicians Associates Board of Trustees
`Chairman, NJMS-University Physicians Associates Board of Trustees
`Member, NJMS-University Physicians Associates Board of Trustees
`Director, Development and Clinical Research
`
`Bielory
`
`5/45
`
`000005
`
`

`
`2/2/16
`
`
`
`1984-1996
`
`1999-2008
`
`1999-2001
`
`Member, American Association of Immunologists
`1988-1995
`Member, American Federation of Clinical Research
`1988-1995
`Fellow, American Association of Certified Allergists
`1987-1995
`1985-1988 Member, Amer. Academy of Allergy, Asthma & Immunology (#11776)
`1988-1995
`Fellow, Amer. Academy of Allergy, Asthma & Immunology (AAAAI)
`1988-1999
`American Academy of Allergy, Asthma & Immunology (AAAAI) Member - Aerobiology
`Committee
` Fellow, Amer. College of Allergy, Asthma & Immunology (#02559)
`1996-1998
`Member, Joint Council of Asthma, Allergy and Immunology Board of Trustees, Chairman -
`Membership Committee
`Fellow, American College of Physicians (#068720)
`Member, American Medical Association (#03305800103)
`Member, American Thoracic Society (#000134421)
`Life Member, Sigma Xi, Scientific Research Society (#869990674)
`
`1986-2011
`1997-2001 Member, Program Committee, American Academy of Allergy, Asthma and Immunology
`1998-2001
`Managed Care Committee, American Academy of Allergy, Asthma and Immunology
`1997-2002
`Medical Informatics: Computers & Technology Committee, American College of Allergy,
`Asthma and Immunology
`Member, Immuno-Ophthalmology Committee, American Academy of Allergy, Asthma and
`Immunology
`Co-Chair AI-MKSAP, American Academy of Allergy, Asthma and Immunology
`Member, Aerobiology Committee, American Academy of Allergy, Asthma and Immunology
`Member, AAAAI Abstract Review Committee
`1997 - 2006
`Member, Allergy and Immunology Training Program Directors
`1985 - 2004
`Member, AAAAI Interest Section Coordinating Committee
`2001 - 2005
`Member, AAAAI TPD-RRC Working Group
`2001 - 2004
`Member, ACAAI Abstract Review Committee,
`2000 - 2009
`Member, ACAAI, Annual Program Committee
`2005- 2007
`Member, ACAAI - Public Education Committee
`2005 - 2007
`Vice Chair, ACAAI - Complementary and Alternative Medicine Committee
`2004 - 2009
`Chair, ACAAI - Ocular Allergy Committee
`2007 - 2009
`Member, ACAAI – CME Committee
`2008 – 2012
`Chair, ACAAI - Integrative Medicine Committee
`2009 – 2010
`2009 – 2010 Member, ACAAI Public relations Committee
`2009 – 2010
`Member, ACAAI Annual Program Committee Meeting
`2009 – 2010
`Member, AAAAI, Abstract Review Committee
`2012 – present Member, ACAAI, Publication Committee
`2012 – present Member, ACAAI, Website Committee
`2012- present Member, ACAAI, Computer On Line for Allergy Oversight Committee
`2011- 2013
`Member, ACAAI Board of Regents
`2012 - 2013
`Member, ACAAI, Continuing Medical Education Committee/Continuing Professional
`Development Committee
`
`
`14.
`
`MAJOR RESEARCH INTERESTS
` Climate Change and Allergic Airway Disease
`
`
`Immuno-Ophthalmology – Ocular Allergy
` Asthma Disease Management & Outcomes
` Complementary & Alternative Medicine
`
`
`Federal Advisory Panels
`2003-2008
`NIH/NCCAM –Univ. of N. Carolina, Center for Environmental Medicine, Asthma&Lung Biology
`1998-2000
`CDC – Yale, Asthma Health Program
`2001-2003
`National Institutes of Health – Study Section – Complementary and Alternative Medicine
`2003-2007
`USP Pharmacopiea – Immunology and Respiratory Group
`
`National Research Advisory Boards/Consultants (past and present)
`
`Bielory
`
`6/45
`
`000006
`
`

`
`2/2/16
`
`Sanofi-Aventis (Aventis) – Pulmonary, Allergy & Infectious Diseases
`
` Merck – Respiratory & Allergy
`
`Fujisawa – Dermatology, Immunology & Allergy
`
`Novartis – Respiratory, Dermatology & Allergy
`
`Forest – Respiratory & Allergy
`
`Inspire – Ophthalmology & Allergy
` Meda (Medpointe)– Ophthalmology & Allergy
`
`EyeTech – Ophthalmology & Allergy
`
`Alcon – Ophthalmology & Allergy
`
`Bausch & Lomb – Ocular Allergy
`
`ISTA – Ophthalmology and Allergy
`
`Allergan – Ophthalmology & Allergy
`
`GlaxoSmithKline – Respiratory & Allergy
`
`AstraZeneca – Respiratory & Allergy
`
`Pfizer – Allergy
`
`UCB Pharma – Allergy
`
`Altana – Respiratory & Allergy
`
`Genentech – Allergy
`
`Genzyme –
`
`Advanced Plant Pharmaceuticals
`
`Schering Plough - Allergy
`
`Santen
`
`Otsuka
`
`ISTA Pharmaceuticals – Ocular Allergy
`
`Novartis – Pediatrics – Allergy - Complemetary and Alternative Medicine
` Wyeth – Allergy and Respiratory
`
`
`15. GRANT HISTORY
`a. Past Grants
`1. UMDNJ Foundation (#10-87); Serum Sickness: A detailed analysis of the human immune response; PI: Dr.
`Bielory-35% effort; Amount each year: $12,000.00; Total amount: $24,000.00; Total period of support:
`July 1986 through December 1988.
`2. Fight for Sight Inc. PD#022-88; Autoantibodies of the optic nerve; PI: Dr. Bielory, 10% effort; Amount
`Each Year $12,000.00; Total amount $12,000.00; Total period of support: July 1, 1988 through June 30,
`1989
`3. NIH-National Institutes of Mental Health; Autoimmune role in the AIDS dementia complex; PI: Dr.
`Schutzer, Dr. Bielory's Effort:10%; Amount each year $82,450.00; Total Amount: $128,595.00; Total
`period of support: September 1, 1988 through August 31, 1990
`4. BRSG-NIH; Sulfa induced drug reactions in AIDS; PI: Dr. Bielory-15% effort; Total support $8,900;
`Period of support: March 1990 - April 1991
`5. Lions Research Foundation of New Jersey; Autoantibodies and the Optic Nerve; P.I. Dr. Bielory - 15%
`effort; Total amount of support - $16,000; May 1990 - June 1991
`6. Sandoz Pharmaceuticals Corp.; Immunologic Disorders of the Visual System; P.I. Dr. Bielory - 10% effort;
`Total amount of support - $25,000; Period of support September 1989 - July 1990.
`7. Lions Eye Research Foundation of New Jersey-Immunological Analysis of Tears, PI: L. Bielory; 10%
`effort; $22,135; October 1990-September 1991
`8. Fight for Sight Inc.; Autoantibodies of the optic nerve; PI: Dr. Frohman; CO-PI: Dr. Bielory, 10% effort;
`$12,000.00; Total amount $12,000.00; Total period of support: July 1, 1990 through June 30, 1991
`9. Sandoz Pharmaceuticals Corp. - Non Transplant Uses of Cyclosporine; PI: L. Bielory; 10% effort; $13,500.
`January 1991 - December 1991.
`10. Eye Institute of New Jersey - Autoantibodies and the Optic Nerve. PI: L. Bielory; 10% effort; $15,000;
`January 1990-December 1991.
`11. New Jersey Fund for the Blind - Autoantibodies and the Optic Nerve. Co-PI: L. Bielory; 10% effort;
`$10,243; December 1990-November 1991.
`12. Protocare Corporation - Intravenous Gammaglobulin and Home Health Care Issues. PI: L. Bielory, M.D.;
`15% effort; $220,000; April 1991 - December 1993.
`
`Bielory
`
`7/45
`
`000007
`
`

`
`2/2/16
`
`13. UMDNJ Foundation - Immunological Analysis of Tears. PI: L. Bielory; 10% effort; $21,087; July 1991 -
`June 1993.
`14. Sandoz Corporation - Intravenous Gammaglobulin and Home Health Care Issues. PI: L. Bielory, M.D.;
`15% effort; $100,000; November 1991 - December 1993.
`15. Abbott Laboratories; Phase III Zileuton study in the treatment of Asthma; PI: L. Bielory, M.D.;10% effort;
`$60,000; June 1993-January 1994.
`16. 3M Pharmaceuticals; Phase III Non-chlorofluorocarbon propellant system for i nhaled bronchodilators
`(SILV-1012); PI: L. Bielory, M.D.; 10% effort; $120,000; September 1993 - April 1994.
`17. Schering Pharmaceuticals; Multicenter Phase IV Quality of Life Comparisons between inhaled anti-
`inflammatory agents (Vanceril¨ and Azmacort¨); PI: L. Bielory, M.D.; 2.5% effort; January 1995 -
`December 1995; $36,000
`18. SmithKline Beecham Pharmaceuticals; Multicenter Phase III Study of novel anti-inflammatory agent in the
`treatment of Asthma; PI: L. Bielory, M.D.; 2.5% effort; $86,100; January 1995-January 1996.
`19. Abbott Laboratories; Multicenter Phase III Long Term Study of Zileuton in the treatment of Asthma; PI: L.
`Bielory, M.D.; 2.5% effort; $33,100; January 1995-January 1996.
`20. Hoescht Marion Roussel Pharmaceuticals; Multicenter Phase III Study of fexofenadine (Allegra¨), a non-
`sedating antihistamine in the treatment of mild to moderate rhinitis in African American patients; PI: L.
`Bielory, M.D.; 2.5% effort; $24,000; March 1996 - June 1996.
`21. Zeneca Pharmaceuticals; Multicenter Phase III Study of zafirlukast (Accolate¨), an anti-inflammatory agent
`in the treatment of mild to moderate Asthma 14 week study; PI: L. Bielory, M.D. with 1 year open label
`option; 2.5% effort; $123,100; August 1995 - March 1996.
`22. Pfizer Pharmaceuticals; Multicenter Phase III Study of cetirizine (Zyrtec¨), a low sedating antihistamine in
`the treatment of mild to moderate rhinitis; PI: L. Bielory, M.D.; 2.5% effort; $36,000; March 1996 - June
`1996.
`23. Zeneca Pharmaceuticals; Multicenter Phase III Study of zafirlukast (Accolate¨), an anti-inflammatory agent
`in the treatment of mild to moderate asthma: Inhaled steroids versus zafirlukast; PI: L. Bielory, M.D.;
`2.5% effort; $136,000; March 1996 - September 1996.
`24. Zeneca Pharmaceuticals; Multicenter Phase III Study of zafirlukast (Accola te¨), an anti-inflammatory
`agent in the treatment of mild to moderate Asthma 3 week study with 1 year open label option; PI: L.
`Bielory, M.D.; 2.5% effort; $136,000; September 1995 - November 1996.
`25. Second Multicenter Asthma Research Collaboration (MARC-2): An observational study of acute asthma
`management; P.I.: Harvard University; Collaborator: L. Bielory, M.D.; 2.5% effort; 3/1/97 - 8/1/97
`26. Zeneca Pharmaceuticals; Multicenter Phase IV Study of zafirlukast (Accolate¨), an anti-inflammatory agent
`in the treatment of mild to moderate Asthma 3 month study; PI: L. Bielory, M.D.; 2.5% effort; $82,500;
`January1997 - June 1997.
`27. Abbott Laboratories Pharmaceuticals, Immunoscience Venture; Multicenter Phase III Study of the efficacy
`of Zileuton 1200 mg BID, Controlled Release (CR), and 600 mg QID, Immediate Release, and placebo in
`Patients with Moderate Asthma; PI: L. Bielory, M.D.; 2.5% effort; $33,100; December 1996 - June 1997.
`28. Merck Corporation - Inner City Asthma Study - Mobile Asthma Van; PI: Leonard Bielory, M.D.; 10%
`effort; 4/30/97 - 8/30/97; Total Cost $15,750.
`29. Third Multicenter Asthma Research Collaboration (MARC-3): Study of acute pediatric asthma
`management; P.I.: Harvard University; Collaborator: L. Bielory, M.D.; 2.5% effort; 9/1/97 - 12/1/97
`30. Glaxo Welcome Corporation - Neuraminidase Inhibitor Treatment for Influenza in High Risk Patients -
`Phase III; PI: Leonard Bielory, M.D.; 10% effort; 1/1/98 - 3/28/98; Total Cost $37,898.
`31. Astral USA, Inc.; A study of the impact of Plutocrat (budesonide) Turbihaler on health outcomes in an
`inner city managed care population; PI: Leonard Bielory, M.D.; 2.5% effort; 6/1/97-11/30/98; Total Cost $
`97,000
`32. Zeneca Pharmaceuticals; Multicenter Phase IV Study of zafirlukast (Accolate¨), an anti-inflammatory agent
`in the treatment of mild to moderate Asthma in children; PI: L. Bielory, M.D.; 1% effort; $36,000; January
`1998 - July 1998.
`33. Glaxo Welcome; Multicenter Phase III Study of a nebulized steroid in the treatment of mild to moderate
`Asthma in children; PI: L. Bielory, M.D.; 2.5% effort; $24,000; August 1998 - December1998.
`34. Forest Pharmaceuticals; Multicenter Phase III Study of a nebulized steroid in the treatment of moderate to
`severe pediatric asthma; PI: L. Bielory, M.D.; 1% effort; $26,000; September 1998 - December1998.
`
`Bielory
`
`8/45
`
`000008
`
`

`
`2/2/16
`
`35. Schering Plough; Multicenter Phase III Study of a mometasone fuorate in comparison to beclomethasone in
`the treatment of asthma in children; PI: L. Bielory, M.D.; 1% effort; $34,000; August 1998 -
`December1998.
`36. Astra Pharmaceuticals; A Multicenter, Multinational, Double Blind Group Comparative Study to
`Investigate the Dose Ranging Effects of Multiple Doses of AR-C68397AA via pMDI Compared with
`Placebo in Adult Patients with Chronic Obstructive Pulmonary Disease. P.I.: L. Bielory, M.D.; 1% effort;
`$73,000; November 1998 – May 1999.
`37. Hoechst-Marion Roussell Pharmaceuticals; A Mulicenter Clinical Trial for the Treatment of Perennial
`Allergic Rhinitis; L. Bielory, M.D.; 1% effort; $26,000; Nov 1998 – March 1999.
`38. Fourth Multicenter Asthma Research Collaboration (MARC-4): An interventional emergency department
`treatment study; P.I.: Harvard University; Collaborator: L. Bielory, M.D.; 2.5% effort; 9/1/98 – 12/1/98
`39. American College of Allergy, Asthma & Immunology; Fellowship Training Grant; P.I.: L. Bielory, M.D.;
`1% effort; $26,000; July 1998 – June 1999.
`40. American College of Allergy, Asthma & Immunology; Training Clinical Investigators (sponsorship for
`fellow Dr. C. Daian); Title of Specific Project – The Effect of Macrolide Antibiotics in the Treatment of
`Moderate to Severe Asthma; Supervising Investigator: L. Bielory, M.D.; 2.5% effort; $10,000; Nov1998 –
`June 2001.
`41. Merck Corporation, SMART (Monteleukast Study); P.I.: L. Bielory, M.D.; 1% effort; $26,000; December
`1999 – Dec 2000
`42. National Institutes of Health, National Heart, Lung and Blood Institute - Raynaud's Treatment
`Study; NO1-HC-25120; PI: Leonard Bielory, M.D.; 35% effort; 9/30/92 - 11/30/00; Total Direct Cost
`$864,898. (Presently in publication phase)
`43. Centers for Disease Control and Prevention, U59/CCU217776-01, Addressing Asthma from A Public
`Health Perspective; P.I. New Jersey Department of Health and Senior Services; Co-Investigator: L. Bielory,
`M.D.; 2.5% effort: 9/1/00-8/31/01; Total Cost $199,957
`44. Otsuka America Pharmaceutical Research 196-01-216; Raynaud’s Study OPC-28326; Phase II,
`Multicenter, randomized, double blind, placebo controlled, Parallel Group Study of the Efficacy and Safety
`of OPC-28326 in subjects with Raynaud ’s Disease; 5%; $65,000
`45. Glaxo Welcome Pharmaceuticals; Gaining Optimal Asthma Control (GOAL): A multicentre, stratified,
`randomized, double-blind, parallel group, step-up comparison of the level of asthma control achieved with
`salmeterol/fluticasone propionate combination Diskusª (Accuhalerª) dry powdered inhaler compared with
`fluticasone propionate Diskusª (Accuhlaerª) alone in adults and adolescents. ; L. Bielory, M.D.; 2.5%
`effort; $47,000; Nov 2000 Ø Nov 2001.
`46. Aventis Pharmaceuticals; A Phase III Multicenter, Double Blind, Placebo Controlled Study Assessing the
`Effects of Ciclesonide Metered Dose Inhaler 50 ug/day and 200 ug/day Administered Once Daily on
`Growth in Children with Mild Persistent or Mild Intermittent Asthma; L. Bielory, M.D.; 2.5% effort;
`$56,000; Nov 2000 – March 2002.
`47. Fight for Sight/Research to Prevent Blindness; Is Raynaud’s Phenomenon a risk factor for non-arteritic
`ischemic optic neuropathy?; Co-Investigator – L. Bielory, M.D. 2.5% effort; 09/01/01 – 08/31/02; Total
`cost $20,000
`48. UMDNJ Foundation – Aventis Pharmaceuticals; American Journal of Medicine Allergy Supplement, P.I.:
`Leonard Bielory, M.D. 5% effort; 09/01/01 – 08/31/02; Total Cost $156,100
`49. Novartis Pharmaceuticals; The Epidemiology and Natural History of Asthma; Outcomes and Treatment
`regimens.; L. Bielory, M.D.; 2.5% effort; $34,000; Dec 2000 – Nov 2005.
`50. Environmental Protection Agency; (Agreement X982553-01-0) Community Based In-Home Asthma
`Environmental Education and Management; Community Resource for Environmental Asthma Management
`(C.R.E.A.M.); P.I. Leonard Bielory, M.D. 5% 10/01/01 – 09/30/03; Total Cost $ 50,000
`51. UMDNJ Foundation – Merck Foundation – United Way; Friendly Fuld Asthma, P.I.: Leonard Bielory,
`M.D. 2.5% effort; 11/01/01 – 10/31/02; Total Cost $30,000
`52. ACGME RFP 2000; Complementary Medicine Education; 5% effort: 7/01/01 – 6/30/03
`53. East Orange Breath EASI; New Jersey Department of Health and Senior Services; Co-P.I.: Leonard
`Bielory, M.D. 5% effort; 100,000 per year 7/01/03 – 6/30/05; Total Cost $200,000; UMDNJ $136,000
`54. HHS - Office of Minority Health (Agreement D52MP01004-01); East Orange Asthma Intervention and
`Relief Project: P.I. Leonard Bielory, M.D. 5% effort in concert with Northern Consortiu10560m 09/01/01-
`08/30/04; Total Cost $146,953 total; UMDNJ $60,576
`
`Bielory
`
`9/45
`
`000009
`
`

`
`2/2/16
`
`55. National Institutes of Health (R13 AT01224-01); Scientifi